Pramomolecular Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $11.7K

  • Investors
  • 4

Pramomolecular General Information

Description

Developer of novel lipid-based gene silencing therapeutics intended to treat currently "undruggable" serious diseases such as non-small cell lung cancer, pancreatic ductal adenocarcinoma, and heart failure. The company offers self-delivering siRNAs, covalently linked, lipid-based ferry molecules that transport nucleic acid-based drugs (NABDs) directly into lung, heart, and pancreatic cells in vivo without the need for external delivery vehicles, enabling customers to efficiently down-regulate disease-causing proteins and develop well-tolerated, effective therapeutics for serious diseases that are currently considered incurable.

Contact Information

Website
www.pramomolecular.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Robert-Rössle-Strasse 10
  • Building D79 / 1st Floor
  • 13125 Berlin
  • Germany
+49 030
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Robert-Rössle-Strasse 10
  • Building D79 / 1st Floor
  • 13125 Berlin
  • Germany
+49 030

Pramomolecular Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pramomolecular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 18-Jul-2025 $11.7K Completed Generating Revenue
4. University Spin-Out 01-Jan-2023 Completed Startup
3. Accelerator/Incubator 01-Jan-2021 Completed Startup
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Pramomolecular’s complete valuation and funding history, request access »

Pramomolecular Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Centre for Entrepreneurship Accelerator/Incubator
Technische Universitat Berlin University
Science4Life Accelerator/Incubator
AXOLOTL (Germany) Accelerator/Incubator
To view Pramomolecular’s complete investors history, request access »

Ready to get started?

Request a free trial

Pramomolecular FAQs

  • When was Pramomolecular founded?

    Pramomolecular was founded in 2021.

  • Where is Pramomolecular headquartered?

    Pramomolecular is headquartered in Berlin, Germany.

  • What industry is Pramomolecular in?

    Pramomolecular’s primary industry is Drug Discovery.

  • Is Pramomolecular a private or public company?

    Pramomolecular is a Private company.

  • What is Pramomolecular’s current revenue?

    The current revenue for Pramomolecular is .

  • How much funding has Pramomolecular raised over time?

    Pramomolecular has raised $11.7K.

  • Who are Pramomolecular’s investors?

    Centre for Entrepreneurship, Technische Universitat Berlin, Science4Life, and AXOLOTL (Germany) have invested in Pramomolecular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process